Renal tolerance of gadolinium-DTPA/dimeglumine in patients with chronic renal failure

Investigative Radiology

Volumn 27, Issue 2, 1992, Pages 153-156

  Haustein, Jens ^a   Niendorf, Hans Peter ^a   Krestin, Gabriel ^b   Louton, Thomas ^a   Schuhmann Giampieri, Gabriele ^a   Clauβ, Wolfram ^a   Junge, Wolfgang ^c  

^a BAYER PHARMA AG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Contrast agent; Gadolinium DTPA; Magnetic resonance imaging; Renal impairment; Urinary enzyme excretion

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

ADULT; AGED; CLINICAL TRIALS; CONTRAST MEDIA; DRUG COMBINATIONS; DRUG TOLERANCE; FEMALE; GADOLINIUM; GADOLINIUM DTPA; HUMAN; KIDNEY; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGE; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; TIME FACTORS;

EID: 0026531049     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/00004424-199202000-00012     Document Type: Article

References (28)

1. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium DTPA complex: a potential NMR contrast agent. AJR 1984;142:619-624.
2. Niendorf HP, Dinger JC, Haustein J, Cornelius I, Alhassan A, Clauβ W. Tolerance of Gd-DTPA: clinical experience. In: Bydder G, Felix R, Bucheler E, Drayer B, Niendorf HP, Takahashi M, Wolf KJ, eds. Contrast media in MRI. Bussum, The Netherlands: Med- icom Europe; 1990:31-39.
3. Schuhmann-Giampicri G, Krestin G. Pharmacokinetics of gadolini- um-DTPA/dimeglumine in patients with chronic renal failure. Invest Radiol 1991. In press.
4. Chasson AL, Grady HJ, Stanley MA. Determination of creatinine by means of automatic chemical analysis. Am J Clin Pathol 1961;35: 83-88.
5. Maruhn D. Preparation of urine for enzyme determinations by gel fdtration. In: Dubach U, Schmidt U, eds. Current Problems in Clinical Biochemistry, Vol. 9. Diagnostic Significance of Enzymes and Proteins in Urine. Bern, Switzerland: Huber; 1979:22.
6. Noto A, Ogawa Y, Mori S, et al. Simple rapid spectrophotometry of urinary N-acetyl-beta-D-glucosamidase, with use of a chromogenic substrate. Clin Chem 1983;29:1713-1716.
7. Bradford MA. Rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein dye binding. Ana Biochem 1986;72:248-252.
8. Helwig JT, Counseil K, eds. SAS User’s Guide. Raleigh, NC: SAS Institute; 1979.
9. Katzberg R. New and old contrast agents: physiology and nephrotoxicity. Urol Radiol 1988;10:6-11.
10. Byrd L, Sherman RL. Radiocontrast-induced acute renal failure: a clinical and pathophysiologic review. Medicine (Baltimore) 1979; 58:270-279.
11. Bems AS. Nephrotoxicity of contrast media. Kidney Int 1989;36:730-740.
12. Teruel JL, Marcen R, Onaindia JM, Serrano A, Quereda C, Ortuno J. Renal function impairment caused by intravenous urography: a prospective study. Arch Intern Med 1981;141:1271-1274.
13. Kumar S, Hull JD, Lathi S, Cohen AJ, Pletka PG. Low incidence of renal failure after angiography. Arch Intern Med 1981; 141:1268-1270.
14. D’Elia JA, Gleason RE, Alday M, et al. Nephrotoxicity from angiographic contrast material: a prospective study. Am J Med 1982;72: 719-725.
15. Parfrcy PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study. N Engl J Med 1989;320: 143-149.
16. Haustein J, Niendorf HP, Louton T. Renal tolerance of Gd-DTPA in 1,171 patients. Radiology 1990; 177(P): 167.
17. Raab WP. Enzymes and isoenzymes in urine. In: Dubach UC, ed. Enzymes in urine and kidney. Baltimore, MD: Williams & Wilkins; 1968:17-55.
18. Price RG. Urinary enzymes, nephrotoxicity and renal disease. Toxicology 1982;23:99-134.
19. Guder W. Enzyme distribution along the nephron. Kidney Int 1984; 26:101-111.
20. Jakobsen JA, Berg KJ, Waaler A, Andrew E. Renal effects of the non-ionic contrast medium iopentol after intravenous injection in healthy volunteers. Acta Radiol 1990;31:87-91.
21. Gale ME, Robbins AH, Hamburger RJ, Widrich WC. Renal toxicity of contrast agents: iopamidol, iothalamate, and diatrizoate. AJR 1984;142:333-335.
22. Nicot GS, Merle LJ, Charmes JP, et al. Transient glomerular proteinuria, enzymuria, and nephrotoxic reaction induced by radiocontrast media. J Am Med Assoc 1984;252:2432-2434.
23. Jevnikar AM, Finnic KJC, Dennis B, Plummer DT, Avila A, Linton AL. Nephrotoxicity of high- and low-osmolality contrast media. Nephron 1988;48:300-305.
24. Severini G, Aliberti LM. Variation of urinary enzymes N-acetyl-beta- glucosaminidase, alanine-aminopeptidase, and lysozymc in patients receiving radio-contrast agents. Clin Biochem 1987:30:339-341.
25. Teyler L, Almen T, Hollas S. Proteinuria following nephroangiogra- phy. Acta Radiol (Diagn) 1977;18:634-640.
26. Khoury GA, Hopper JC, Varghese Z, et al. Nephrotoxicity of ionic and non-ionic contrast material in digital vascular imaging and selective renal arteriography. Br J Radiol 1983;56:631-635.
27. Lackner K, Krahe T, Gotz R, Haustein J. The dialysability of gado- linium-DTPA. In: Bydder G, Felix R, Bucheler E, Drayer B, Niendorf HP, Takahashi M, Wolf KJ, eds. Contrast media in MRI. Bussum, The Netherlands: Medicom Europe; 1990:321-326.
28. Haustein J, Schuhmann-Giampieri G. Elimination of Gd-DTPA by means of hemodialysis. Eur J Radiol 1990;11:227-229.